These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6815051)

  • 1. Toxic cardiomyopathy due to doxorubicin.
    Bristow MR
    Hosp Pract (Off Ed); 1982 Dec; 17(12):101-8, 110-1. PubMed ID: 6815051
    [No Abstract]   [Full Text] [Related]  

  • 2. Adriamycin and the heart.
    Henderson IC; Frei TE
    N Engl J Med; 1979 Feb; 300(6):310-2. PubMed ID: 759884
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxorubicin cardiomyopathy.
    Abelmann WH
    Hosp Pract (Off Ed); 1982 Dec; 17(12):17-8. PubMed ID: 6815059
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.
    Friedman MA; Bozdech MJ; Billingham ME; Rider AK
    JAMA; 1978 Oct; 240(15):1603-6. PubMed ID: 691145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?
    Geffen DB; Liel-Cohen N
    Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640
    [No Abstract]   [Full Text] [Related]  

  • 6. Anthracycline cardiotoxicity: recognition, management, and avoidance.
    Mason JW
    Compr Ther; 1979 Jul; 5(7):64-8. PubMed ID: 477286
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiotoxicity of doxorubicin in children].
    Pilon JW; Naeff MS; Taminiau JA
    Ned Tijdschr Geneeskd; 1984 Jul; 128(28):1339-43. PubMed ID: 6482993
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy.
    Singal PK; Siveski-Iliskovic N; Hill M; Thomas TP; Li T
    J Mol Cell Cardiol; 1995 Apr; 27(4):1055-63. PubMed ID: 7563102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anthracyclin-cardiomyopathy (author's transl)].
    Kothe K; Ihle R; Romaniuk P; Stobbe H; Wagenknecht C
    Arch Geschwulstforsch; 1982; 52(2):141-54. PubMed ID: 6213212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of
    Li LP; Zhong J; Li MH; Sun YC; Niu YJ; Wu CH; Zhou JF; Norton N; Li ZQ; Shi YY; Xu XL; Ding YH
    Biomed Res Int; 2021; 2021():8569921. PubMed ID: 34327238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac effects of doxorubicin therapy of neoplasms.
    Ugoretz RJ
    JAMA; 1976 Jul; 236(3):295-6. PubMed ID: 947037
    [No Abstract]   [Full Text] [Related]  

  • 13. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.
    Simsir SA; Lin SS; Blue LJ; Gockerman JP; Russell SD; Milano CA
    Ann Thorac Surg; 2005 Aug; 80(2):717-9. PubMed ID: 16039240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.
    Bristow MR; Mason JW; Billingham ME; Daniels JR
    Ann Intern Med; 1978 Feb; 88(2):168-75. PubMed ID: 626445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy.
    Bristow MR; Mason JW; Billingham ME; Daniels JR
    Am Heart J; 1981 Oct; 102(4):709-18. PubMed ID: 7282516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin cardiomyopathy.
    Chatterjee K; Zhang J; Honbo N; Karliner JS
    Cardiology; 2010; 115(2):155-62. PubMed ID: 20016174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doxorubicin-induced cardiomyopathy].
    Czarnecki A
    Pol Tyg Lek; 1983 Apr; 38(15):471-3. PubMed ID: 6356084
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiotoxicity of antitumor agents.
    Kantrowitz NE; Bristow MR
    Prog Cardiovasc Dis; 1984; 27(3):195-200. PubMed ID: 6387802
    [No Abstract]   [Full Text] [Related]  

  • 20. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy.
    Campos EC; O'Connell JL; Malvestio LM; Romano MM; Ramos SG; Celes MR; Prado CM; Simões MV; Rossi MA
    Eur J Pharmacol; 2011 Nov; 670(2-3):541-53. PubMed ID: 21946105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.